Cold‐stored platelet function is not significantly altered by agitation or manual mixing

Abstract Background Cold storage of platelets (CS‐PLT), results in better maintained hemostatic function compared to room‐temperature stored platelets (RT‐PLT), leading to increased interest and use of CS‐PLT for actively bleeding patients. However, questions remain on best storage practices for CS‐PLT, as agitation of CS‐PLT is optional per the United States Food and Drug Administration. CS‐PLT storage and handling protocols needed to be determined prior to upcoming clinical trials, and blood banking standard operating procedures need to be updated accordingly for the release of units due to potentially modified aggregate morphology without agitation. Study Design and Methods We visually assessed aggregate formation, then measured surface receptor expression (GPVI, CD42b (GPIbα), CD49 (GPIa/ITGA2), CD41/61 (ITGA2B/ITGB3; GPIIB/GPIIIA; PACI), CD62P, CD63, HLAI), thrombin generation, aggregation (collagen, adenosine diphosphate [ADP], and epinephrine activation), and viscoelastic function (ExTEM, FibTEM) in CS‐PLT (Trima collection, 100% plasma) stored for 21 days either with or without agitation (Phase 1, n = 10 donor‐paired units) and then without agitation with or without daily manual mixing to minimize aggregate formation and reduce potential effects of sedimentation (Phase 2, n = 10 donor‐paired units). Results Agitation resulted in macroaggregate formation, whereas no agitation caused film‐like sediment. We found no substantial differences in CS‐PLT function between storage conditions, as surface receptor expression, thrombin generation, aggregation, and clot formation were relatively similar between intra‐Phase storage conditions. Discussion Storage duration and not condition impacted phenotype and function. CS‐PLT can be stored with or without agitation, and with or without daily mixing and standard metrics of hemostatic function will not be significantly altered.